Antunović Marijaa, Raonić Janjab, Vučković Ljiljanab
aFaculty of Medicine, Clinical Center of Montenegro, Department for Oral surgery, Podgorica, Montenegro
bFaculty of Medicine, Clinical Center of Montenegro, Center for Pathology, Podgorica, Montenegro
Abstract
Background/Aim: Many studies confirmed strong association between oncogenic genotypes of Human Papillomaviruses (HPVs) and some oropharyngeal and oral squamous cell carcinomas (OSCCs). The aim of this study was to determine the prognostic significance of HPV16 infection in OSCC in population of Montenegro i.e. correlation between HPV16 infection and disease free interval (DFI), disease recurrence and metastasis occurrence. Material and Methods: We examined surgically obtained specimens from 60 patients with OSCC (localized on the lower lip, tongue or/and floor of the mouth) in six years period. Tumor tissue samples were used for histological analysis and HPV16 genome PCR detection (primers for detection of E6 gene). Patients were followed up for the 3 years. Results: HPV16 infection was more commonly detected in females with OSCC (p=0.038), while no correlation between this infection and disease recurrence (p= 0.122) and/or metastasis occurrence (p= 0.934) was found. DFI was not significantly different between patients with or without HPV16 infection (p= 0.427), but DFI was significantly shorter (p= 0.003) in females with oral HPV16 infection compared to male patients with this infection. Conclusions: Counting that HPV16 infection has a negative prognostic significance in OSCC, the HPV immunization program against genital HPV infection, would also have a positive impact on the frequency of HPV-mediated OSCC in Montenegrin population.
Keywords: HPV16-related oral cancer; prognosis; immunization
Reference
Bertolus C, Goudot P, Gessain A, Berthet N. Clinical relevance of systematic human papillomavirus (HPV) diagnosis in oral squamous cell carcinoma. Infect Agent Cancer, 2012;7:13
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. 2002. CA Cancer J Clin, 2005;55:74-108
Castellsaque X, Quintana MJ, Martinez MC, Nieto A, Sanchez MJ, Juan A, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int. J Cancer, 2004;108:741-749
Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol, 2001;13:183-188
D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 2007;356:1944-1956
Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine, 2012;30:F12-23
Buchanan TR, Graybill WS, Pierce JY. Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines. Hum Vaccines Immunother, 2016;12:1352-1356
De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer, 2017; 141:664-670
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KS, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003;348;518-527
Syrjanen KJ, Pyrhonen S, Syrjanen SM, Lamberg MA. Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Brit J Oral Surg, 1983;21:147-153
Bosch FX, Lorincz A, Muñoz, N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002;55:244-265
Thompson IO, van der Bijl P, van Wyk CW, van Eyk AD. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol, 2001;46:1091-1098
Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001;91:622-635
Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Trans Dis, 2014;41:660-664
Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 2005;366:991-998
Aimee R. Kreimer, Gary M. Clifford, Peter Boyle, Silvia Franceschi. Human papillomavirus types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review. Cancer Epidemiol Biomarkers Prev, 2005;14:467-475
Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, et al. HPV in oral squamous cell carcinoma vs. head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol, 2008;19:1681-90
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, et al. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PL0S ONE, 2012;7:e40767
Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg, 2001;125:1-9
Sugiyama M, Bhawal UK, Kawamura M, Ishioka Y, Shigeishi H, Higashikawa K, et al. Human papilloma virus16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg, 2007;45:116-122
Zhao D, Xu QG, Chen XM, Fan MW. Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral Sci, 2009;1:119-125
Mark J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Engl J Med, 2001;344:1125-1131
Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol, 2005;125:1337-1344
Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol, 2004;57:449-455
Syrjanen S. Human papillomaviruses in the head and neck carcinomas. N Engl J Med, 2007; 365:1993-1995
Kozomara R. Importance of p53 antioncogene and human papilloma virus for radioresistance of oral squamous cell carcinoma of tongue and floor of the mouth [PhD Thesis]. Belgrade: Military Medical Academy, 2003. (in Serbian)
Acay R, Rezende N, Fontes A, Aburad A, Nunes F, Sousa S. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification. Oral Microbiol Immunol, 2008;23:271-274
Anaya-Saavedra G, Ramirez-Amador V, Irigoyen-Camacho ME, Garcia-Cuellar CM, Guido-Jimenez M, Mendez-Martinez R, et al. High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res, 2008;39:189-197
Ostwald C, Muller P, Barten M, Rutsatz K, Sonnenburg M, Milde-Langosch K, et al. Human papilloma virus DNA in oral squamous cell carcinoma and normal mucosa. J Oral Pathol Med, 1994;23:220-225
Kreimer AR, Villa A, Nyitray AG, Abrahamsen M, Papenfuss M, Smith D, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev, 2011;20:172-182
Rintala MA, Grenman SE, Jarvenkyla ME, Syrjänen KJ, Syrjänen SM. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis, 2005;41:1728-1733
Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev, 2000;9:433-437
Butz K, Geisen C, Ullmann A, Spitkovsky D. Cellular responses of HPV-positive cancer cells to genotoxic anticancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer, 1999;68:506-513
Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev, 2011;12:889-896
Kim, KS, Park, S, Ko, K-N, Yi, S, Cho, YJ. Current status of human papillomavirus vaccines. Clin Exp Vaccine Res, 2014;3:168-175
Pils, S, Joura, E. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect, 2015;21:827-833
Näsman A, Du J, Dalianis T. A global epidemic increase of an HPV-induced tonsil and tongue base cancer -potential benefit from a pan-gender use of HPV vaccine. J Intern Med, 2020;287:134-152
The future II study group. Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N Engl J Med, 2007;356:1915-1927
Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol, 2007;107:S19-S26
Balkan Journal of Dental Medicine, 2023, vol. 27, br. 1, str. 38-42